PETE GARCIA COMPANY – Trademark Portfolio
Entity Type: 03
PETE GARCIA COMPANY holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include IN-FAX, MAX THE FAX, THE BEST LINES IN THE WORLD, and THE BEST LINES IN THE COUNTRY. The owner is based in ATLANTA, GA.
5154 PEACHTREE INDUSTRIAL BOULEVARD
ATLANTA, GA 30341
Showing of trademarks Trademarks
Trademark Classifications
PETE GARCIA COMPANY's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does PETE GARCIA COMPANY have?
PETE GARCIA COMPANY has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 2 cancelled.
What trademark classes does PETE GARCIA COMPANY file in?
PETE GARCIA COMPANY files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 17 (Rubber Goods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are PETE GARCIA COMPANY's most well-known trademarks?
PETE GARCIA COMPANY's registered trademark portfolio includes well-known marks such as IN-FAX, MAX THE FAX, THE BEST LINES IN THE WORLD, and THE BEST LINES IN THE COUNTRY. These are among 4 currently registered trademarks in the portfolio.
What is PETE GARCIA COMPANY's trademark registration success rate?
PETE GARCIA COMPANY has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.